CORCEPT THERAPEUTICS INC financial data

Symbol
CORT on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305% % -29%
Quick Ratio 8.3% % 7%
Debt-to-equity 27% % 26%
Return On Equity 15% % -33%
Return On Assets 12% % -36%
Operating Margin 5.9% % -71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 106,374,020 shares 0.31%
Common Stock, Shares, Outstanding 105,966,000 shares 0.81%
Entity Public Float $6,107,076,423 USD 127%
Common Stock, Value, Issued $140,000 USD 2.9%
Weighted Average Number of Shares Outstanding, Basic 103,862,000 shares 0.61%
Weighted Average Number of Shares Outstanding, Diluted 119,987,000 shares 5.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $761,407,000 USD 13%
Research and Development Expense $254,908,000 USD 3.2%
Costs and Expenses $716,610,000 USD 33%
Operating Income (Loss) $44,797,000 USD -67%
Nonoperating Income (Expense) $21,666,000 USD -12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $66,463,000 USD -59%
Income Tax Expense (Benefit) $33,189,000 USD -264%
Net Income (Loss) Attributable to Parent $99,652,000 USD -29%
Earnings Per Share, Basic 0.95 USD/shares -30%
Earnings Per Share, Diluted 0.82 USD/shares -33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $120,495,000 USD -5.6%
Marketable Securities, Current $251,657,000 USD -1.6%
Accounts Receivable, after Allowance for Credit Loss, Current $59,786,000 USD 11%
Inventory, Net $12,868,000 USD 3.7%
Other Assets, Current $7,102,000 USD 17%
Assets, Current $485,464,000 USD 2.9%
Deferred Income Tax Assets, Net $168,197,000 USD 28%
Property, Plant and Equipment, Net $1,890,000 USD -30%
Operating Lease, Right-of-Use Asset $4,583,000 USD -14%
Other Assets, Noncurrent $5,153,000 USD -22%
Assets $836,651,000 USD -0.46%
Accounts Payable, Current $40,444,000 USD 163%
Accrued Liabilities, Current $90,603,000 USD -0.11%
Liabilities, Current $166,085,000 USD 18%
Accrued Income Taxes, Noncurrent $15,176,000 USD 7.8%
Operating Lease, Liability, Noncurrent $5,023,000 USD -18%
Liabilities $188,846,000 USD 17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,264,000 USD
Retained Earnings (Accumulated Deficit) $643,387,000 USD 18%
Stockholders' Equity Attributable to Parent $647,805,000 USD -4.7%
Liabilities and Equity $836,651,000 USD -0.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,128,000 USD -78%
Net Cash Provided by (Used in) Financing Activities $39,803,000 USD -7230%
Net Cash Provided by (Used in) Investing Activities $3,171,000 USD 65%
Common Stock, Shares Authorized 280,000,000 shares 0%
Common Stock, Shares, Issued 142,518,000 shares 3.5%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37,846,000 USD -367%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $120,495,000 USD -5.6%
Deferred Tax Assets, Valuation Allowance $20,926,000 USD 20%
Deferred Tax Assets, Gross $190,502,000 USD 27%
Operating Lease, Liability $6,107,000 USD -12%
Payments to Acquire Property, Plant, and Equipment $104,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $102,133,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid $7,350,000 USD -16%
Operating Lease, Liability, Current $1,084,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,598,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,551,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.085 pure 0%
Deferred Income Tax Expense (Benefit) $13,705,000 USD -91%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,243,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,646,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $93,672,000 USD 2599%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $22,929,000 USD 39%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,695,000 USD 3%
Operating Lease, Payments $1,382,000 USD 1.8%
Additional Paid in Capital $832,108,000 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $52,000 USD -56%
Depreciation, Depletion and Amortization $285,000 USD 138%
Deferred Tax Assets, Net of Valuation Allowance $168,197,000 USD 28%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%